Prognostic Significance of the Left Ventricular Diastolic Score: A Project Baseline Health Study

Gracia Fahed,Everton Santana,Nicholas Cauwenberghs,Bettia Celestin,Megan Carroll,Sarah A. Short,Kevin M. Alexander,Shadi P. Bagherzadeh,Kenneth W. Mahaffey,Adrian F. Hernandez,Svati H. Shah,Michael Salerno,Pamela S. Douglas,Tatiana Kusnetsova,Melissa A. Daubert,Francois Haddad
DOI: https://doi.org/10.1101/2024.06.06.24308550
2024-06-07
Abstract:Background: Left ventricular diastolic dysfunction (LVDD) is an important predictor of cardiovascular outcomes. LVDD assessment guidelines are valuable in clinical practice, yet a significant proportion of individuals remain indeterminate. Objectives: We aimed to develop an easy-to-use LVDD score and compare its prognostic value to American Society of Echocardiography (ASE) and European Association of Cardiovascular Imaging (EACVI) guidelines. Methods: Participants in the Project Baseline Health Study (PBHS) were included (n=1,952). Minor and major criteria for the PBHS diastolic score (0-6 points) were defined by percentile deviation from a healthy reference cohort (n=565), including early mitral annular tissue Doppler velocity (e'), the ratio of early diastolic inflow velocity to e' (E/e'), and left atrial volume index. Multivariable Cox regression estimated associations between LVDD assessments and major adverse cardiovascular events (MACE). Results: At enrollment, mean age was 50±16; 56% were female. LVDD according to ASE/EACVI guidelines was present in 8.4% of participants, of whom 54.3% had an indeterminate grade. PBHS diastolic scores of ≥3 and ≥4 were observed in 14.1% and 5.8%, respectively. ASE/EACVI grades 2-3 corresponded with PBHS scores >3, whereas indeterminate categories corresponded with scores of 1-5. After multivariable adjustment, both LVDD grading systems equally predicted MACE (ASE/EACVI grades 2-3: aHR 5.7 [95%CI: 3.01-10.7]; PBHS scores 4 and 5-6: aHRs 2.3 [95%CI: 1.25-4.33] and 5.3 [95%CI: 2.44-11.56], respectively). Conclusion: The PBHS diastolic score predicted MACE similarly to the ASE/EACVI. Its simplicity and prognostic value can make it useful in clinical settings, particularly for quantifying abnormalities and risk-stratifying patients with indeterminate LVDD.
What problem does this paper attempt to address?